Trial Profile
An Open Label Extension Study to Evaluate Safety, Tolerability, and Efficacy of 18 Weeks of Valsartan Treatment in Children 6 Months-5 Years Old With Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 May 2021
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis Pharma A.G.
- 23 Oct 2013 New trial record